Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

KCNC3 Inhibitors

KCNC3 inhibitors encompasses a multifaceted collection of organic molecules, each distinguished by their unique capacity to intricately modulate the activity of the KCNC3 protein, also recognized as Kv3.3. This particular protein stands as a pivotal player among voltage-gated potassium channels, asserting its influence predominantly within neuronal environments. By meticulously regulating the initiation and propagation of action potentials, KCNC3 profoundly impacts the overall excitability of neurons, thereby dictating intricate processes underlying neural communication and signaling. At the crux of KCNC3 inhibitors lies a meticulous ability to interact selectively with the functional domains or binding sites intrinsic to the KCNC3 protein structure. This interaction, carefully orchestrated by the inhibitors, engenders a regulatory role over the flux of potassium ions through cellular membranes, a process essential for establishing and maintaining the membrane potential critical for neuronal electrical activity. By precisely targeting and engaging KCNC3, these inhibitors hold the potential to curate a controlled modulation of neural excitability, potentially influencing diverse physiological aspects dependent on finely-tuned neuronal signaling. The journey to develop KCNC3 inhibitors is a confluence of scientific disciplines, harmonizing computational simulations, medicinal chemistry, and rigorous experimental validation. This intricate synergy facilitates the identification of compounds that demonstrate a distinct predilection for KCNC3, illuminating a path toward precision and selectivity in modulating neuronal activity. The realm of KCNC3 inhibitors remains intrinsically woven into the intricate tapestry of neurobiology, presenting an avenue to further decipher the nuances of neuronal communication, the mechanisms underpinning excitability, and the broader physiological repercussions engendered by these molecules' subtle yet profound influence.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Riluzole

1744-22-5sc-201081
sc-201081A
sc-201081B
sc-201081C
20 mg
100 mg
1 g
25 g
$20.00
$189.00
$209.00
$311.00
1
(1)

Riluzole is a compound that has been investigated for its potential to inhibit KCNC3 channels. It is primarily used as a drug for amyotrophic lateral sclerosis (ALS) and has been shown to modulate neuronal excitability by affecting various ion channels, including KCNC3.